Martin Rutkowski MD

Martin Rutkowski MD

Expected Graduation Date: 2018

 

 

 

 


Education, Training, and Previous Positions

2012: MD, David Geffen School of Medicine at UCLA, Los Angeles, CA
2005: BA, Brown University, Providence, RI

Selected Honors and Awards

2010: UCSF Oral Presentation, Doris Duke Clinical Foundation National Meeting, Dallas, TX
2010: UCSF PACCTR Extended Support, University of California, San Francisco
2009: Doris Duke Clinical Research Fellowship, University of California, San Francisco
2007: American Heart Association Medical Student Research Fellowship, University of California, San Francisco
2005: Bishop McVickar Award, Brown University, Providence, RI
2005: magna cum laude, Brown University, Providence, RI

Selected Recent Publications

Rutkowski MJ, Breshears JD, Kunwar S, Aghi MK, Blevins LS. Approach to the postoperative patient with Cushing's disease. Pituitary. 2015 Apr;18(2):232-7.

Rutkowski MJ, Flanigan PM, Aghi MK. Update on the management of recurrent Cushing's disease. Neurosurg Focus. 2015 Feb;38(2):E16.

Englot DJ, Rutkowski MJ, Ivan ME, Sun PP, Kuperman RA, Chang EF, Gupta N, Sullivan JE, Auguste KI. Effects of temporal lobectomy on consciousness-impairing and consciousness-sparing seizures in children. Childs Nerv Syst. 2013 Oct;29(10):1915-22.

Oh T, Rutkowski MJ, Safaee M, Sun MZ, Sayegh ET, Bloch O, Tihan T, Parsa AT. Survival outcomes of giant cell glioblastoma: institutional experience in the management of 20 patients. J Clin Neurosci. 2014 Dec;21(12):2129-34.

Bloch O, Crane CA, Kaur R, Safaee M, Rutkowski MJ, Parsa AT. Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages. Clin Cancer Res. 2013 Jun 15;19(12):3165-75.

Huang T, Mueller S, Rutkowski MJ, Han SJ, Bloch O, Barani IJ, Parsa AT, Chang SM. Multidisciplinary care of patients with brain tumors. Surg Oncol Clin N Am. 2013 Apr;22(2):161-78. doi: 10.1016/j.soc.2012.12.011. Epub 2013 Jan 10. Review. PubMed PMID: 23453330.

Sughrue ME, Rutkowski MJ, Chen CJ, Shangari G, Kane AJ, Parsa AT, Berger MS, McDermott MW. Modern surgical outcomes following surgery for sphenoid wing meningiomas. J Neurosurg. 2013 Jul;119(1):86-93. doi: 10.3171/2012.12.JNS11539. Epub 2013 Feb 22. PubMed PMID: 23432379.

Mills SA, Oh MC, Rutkowski MJ, Sughrue ME, Barani IJ, Parsa AT. Supratentorial hemangioblastoma: clinical features, prognosis, and predictive value of location for von Hippel-Lindau disease. Neuro Oncol 2012;14(8):1097-104.

Han SJ, Oh MC, Sughrue ME, Rutkowski MJ, Aranda D, Barani IJ, Parsa AT. The effect of the 2003 Consensus Reporting Standards on publications describing patients with vestibular schwannoma treated with stereotactic radiosurgery. J Clin Neurosci 2012;19(8):1144-7.

Barrows BD, Rutkowski MJ, Gultekin SH, Parsa AT, Tihan T. Evidence of ambiguous differentiation and mTOR pathway dysregulation in subependymal giant cell astrocytoma. Tuk Patoloji Derg 2012;28(2):95-103.

Han SJ, Oh MC, Sughrue ME, Aranda D, Rutkowski MJ, Parsa AT. Reporting standard compliance in publications of vestibular schwannoma patients treated with microneurosurgery. Otol Neurotol 2012;33(4):648-50.

Kane AJ, Sughrue ME, Rutkowski MJ, Aranda D, Mills SA, Lehil M, Fang S, McDermott MW, Parsa AT. Atypia predicts prognosis for intracranial extraventricular neurocytomas. J Neurosurg 2012;116(2):349-54.

Rutkowski MJ, Jian BJ, Bloch O, Chen C, Sughrue ME, Tihan T, Barani IJ, Berger MS, McDermott MW, Parsa AT. Intracranial hemangiopericytoma: clinical experience and treatment considerations in a modern series of 40 adult patients. Cancer 2012;118(6):1628-36.

Rutkowski MJ, Bloch O, Jian BJ, Chen C, Sughrue ME, Tihan T, Barani IJ, Berger MS, McDermott MW, Parsa AT. Management of recurrent intracranial hemangiopericytoma. J Clin Neurosci 2011;18(11):1500-4. Tate MC, Rutkowski MJ, Parsa AT. Contemporary management of pineoblastoma. Neurosurg Clin N Am 2011;22(3):409-12.

Tate M, Sughrue ME, Rutkowski MJ, Kane AJ, Aranda D, McClinton L, McClinton L, Barani IJ, Parsa AT. The long term postsurgical prognosis of patients with pineoblastoma. Cancer 2012;118(1):173-9.

Sughrue ME, Choi J, Rutkowski MJ, Aranda D, Kane AJ, Barani IJ, Parsa AT. Clinical features and post-surgical outcome of patients with astroblastoma. J Clin Neurosci 2011;18(6):750-4.

Kane AJ, Sughrue ME, Rutkowski MJ, McDermott MW, Berger MS, Parsa AT. Clinical and surgical considerations for cerebellopontine angle meningiomas. J Clin Neurosci 2011;18(6):755-9.

Rutkowski MJ, Sughrue ME, Kane AJ, Kim JM, Bloch O, Parsa AT. Epidermal growth factor module-containing mucin-like receptor 2 is a newly identified adhesion G protein-coupled receptor associated with poor overall survival and an invasive phenotype in glioblastoma. J Neurooncol 2011;105(2):165-71.

Kane AJ, Sughrue ME, Rutkowski MJ, Shangari G, Fang S, McDermott MW, Berger MS, Parsa AT. Anatomic location is a risk factor for atypical and malignant meningiomas. Cancer 2011;117(6):1272-8.

Sughrue ME, Rutkowski MJ, Shangari G, Fang S, Parsa AT, Berger MS, McDermott MW. Incidence, risk factors, and outcome of venous infarction after meningioma surgery in 705 patients. J Clin Neurosci 2011;18(5):628-32.

Sughrue ME, Kaur R, Rutkowski MJ, Kane AJ, Kaur G, Yang I, Pitts LH, Parsa AT. Extent of resection and the long term durability of vestibular schwannoma surgery. J Neurosurg 2011;114(5):1218-23.

Jian BJ, Sughrue ME, Kaur R, Rutkowski MJ, Kane AJ, Kaur G, Yang I, Pitts LH, Parsa AT. Implications of cystic features in vestibular schwannomas of patients undergoing microsurgical resection. Neurosurgery 2011;68(4):874-80.

Sughrue ME, Kaur R, Rutkowski MJ, Kane AJ, Pitts LH, Cheung SW, Parsa AT. A critical evaluation of vestibular schwannoma surgery for patients less than 40 years of age. Neurosurgery 2010;67(6):1646-54.

Sughrue ME, Yang I, Rutkowski MJ, Aranda D, Parsa AT. Preservation of facial nerve function after resection of vestibular schwannoma. Br J Neurosurg 2010;24(6):666-71.

Sughrue ME, Rutkowski MJ, Shangari G, Parsa AT, Berger MS, McDermott MW. Results with judicious modern neurosurgical management of parasagittal and falcine meningiomas. J Neurosurg 2011;114(3):731-7. Kane AJ, Sughrue ME, Rutkowski MJ, Tihan T, Parsa AT. The molecular pathology of central neurocytomas. J Clin Neurosci 2011;18(1):1-6.

Rutkowski MJ, Sughrue ME, Kane AJ, Mills SA, Parsa AT. Cancer and the complement cascade. Mol Cancer Res 2010;8(11):1453-65.

Sughrue ME, Rutkowski MJ, Kane AJ, Parsa AT. Human glioma demonstrates cell line specific results with ATP-based chemiluminescent cellular proliferation assays. J Clin Neurosci 2010;17(12):1573-7.

Kane AJ, Sughrue ME, Rutkowski MJ, Phillips JJ, Parsa AT. EMR3: A potential mediator of invasive phenotypic variation in glioblastoma and novel therapeutic target. Neuroreport 2010;21(16):1018-22.

Bloch O, Sughrue ME, Kaur R, Kane AJ, Rutkowski MJ, Kaur G, Yang I, Pitts LH, Parsa AT. Factors associated with preservation of facial nerve function after surgical resection of vestibular schwannoma. J Neurooncol 2011;102(2):281-6.

Sughrue ME, Rutkowski MJ, Shangari G, Chang HQ, Parsa AT, Berger MS, McDermott MW. Risk factors for the development of serious medical complications after resection of meningiomas. J Neurosurg 2011;114(3):697-704.

Sughrue ME, Rutkowski MJ, Chang EF, Shangari G, Kane AJ, McDermott MW, Berger MS, Parsa AT. Postoperative seizures following the resection of convexity meningiomas: are prophylactic anti-convulsants indicated? J Neurosurg 2011;114(3):705-9.

Sughrue ME, Kaur R, Kane AJ, Rutkowski MJ, Yang I, Pitts LH, Tihan T, Parsa AT. Intratumoral hemorrhage and fibrosis in vestibular schwannoma: a possible mechanism for hearing loss. J Neurosurg 2011;114(2):386-93.

Rutkowski MJ, Sughrue ME, Kane AJ, Ahn BJ, Fang S, Parsa AT. The complement cascade as a mediator of tissue growth and regeneration. Inflamm Res 2010;59(11):897-905.

Sughrue ME, Kane AJ, Kaur R, Barry JJ, Rutkowski MJ, Pitts LH, Cheung SW, Parsa AT. A prospective study of hearing preservation in untreated vestibular schwannomas. J Neurosurg 2011;114(2):381-5.

Sughrue ME, Kaur R, Kane AJ, Rutkowski MJ, Kaur G, Yang I, Pitts LH, Parsa AT. The value of intraoperative facial nerve electromyography in predicting facial nerve function after vestibular schwannoma surgery. J Clin Neurosci 2010;17(7):849-52.

Clark AJ, Sughrue ME, Ivan ME, Aranda D, Rutkowski MJ, Kane AJ, Chang S, Parsa AT. Factors influencing overall survival rates for patients with pineocytoma. J Neurooncol 2010;100(2):255-260.

Sughrue ME, Rutkowski MJ, Aranda D, Barani I, McDermott MW, Parsa AT. Factors affecting outcome following treatment of patients with cavernous sinus meningiomas. J Neurosurg 2010;113(5):1087-92.

Sughrue ME, Rutkowski MJ, Aranda D, Barani IJ, McDermott MW, Parsa AT. Treatment decision making based on the published natural history and growth rate of small meningiomas. J Neurosurg 2010;113(5):1036-42.

Rutkowski MJ, Sughrue ME, Kane AJ, Mills SA, Fang S, Parsa AT. Complement and the central nervous system: emerging roles in development, protection, and regeneration. Immunol Cell Biol 2010;88(8):781-6.

Sughrue ME, Kane AJ, Rutkowski MJ, Shangari G, Berger MS, McDermott MW, Parsa AT. The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas. J Neurosurg 2010;113(5):1029-35.

Yang I, Sughrue ME, Rutkowski MJ, Kaur R, Ivan M, Aranda D, Barani IJ, Parsa AT. Craniopharyngioma: a comparison of tumor control with various treatment strategies. Neurosurg Focus 2010;28(4):E5.

Rutkowski MJ, Sughrue ME, Kane AJ, Aranda D, Mills SA, Barani I, Parsa AT. Predictors of mortality following treatment for intracranial hemangiopericytoma. J Neurosurg 2010;113(2):333-9.

Kane AJ, Sughrue ME, Rutkowski MJ, Aranda D, Mills SA, Buencamino R, Fang S, Barani I, Parsa AT. Posttreatment prognosis of patients with esthesioneuroblastoma. J Neurosurg 2010;113(2):340-51.

Sughrue ME, Yang I, Aranda D, Rutkowski MJ, Fang S, Cheung SW, Parsa AT. Beyond audiofacial morbidity after vestibular schwannoma surgery. J Neurosurg 2011;114(2):367-74.

Sughrue ME, Yeung AH, Rutkowski MJ, Cheung SW, Parsa AT. Molecular biology of familial and sporadic vestibular schwannomas: implications for novel therapeutics. J Neurosurg 2011;114(2):359-66.

Sughrue ME, Yang I, Kane AJ, Rutkowski MJ, Fang S, James CD, Parsa AT. Immunological considerations of modern animal models of malignant primary brain tumors. J Transl Med 2009;7(1):84.

Ko NU, Rajendren R, Kim H, Rutkowski MJ, Pawlikowska L, Kwok PL, Higashida RT, Lawton MT, Smith WS, Zaroff JG, Young WL. Endothelial nitric oxide synthase polymorphism (-786T->C) and increased risk of angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2008;39(4):1103-8.